Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseLife at Premier By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Consulting Reimbursement Rules & Considerations for Medical Device Development in Asia By Ashish Jain January 8, 2020 Clinical ResearchPhase 1 - Phase 4 Considerations for Operationalizing Pediatric Oncology Studies By Premier Research December 18, 2019 Consulting 4 APAC Countries With Shifting Medical Device Regulations: What You Need to Know By Ashish Jain December 4, 2019 Patient and Stakeholder Engagement Chance Connections Become New Relationships at Global Genes By Premier Research November 20, 2019 Clinical ResearchPhase 1 - Phase 4 Understanding Recent Regulatory Changes for Pediatric Oncology Trials By Kristi Miller November 13, 2019 Consulting The Role Of Notified Bodies Under The EU Medical Devices Regulation By Janet Kube August 28, 2019 Previous 1 …23 24 25 26 27 … 57 Next × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Gene Therapy 101: From the 1960s to Today